Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol/betamethasone scalp psoriasis gel comparison study
2016-001106-42Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone in psoriasis (3 arms), sponsored by Dermapharm. Primary endpoint: Change in modified Total Severity Sign Score. Started Jul 2016; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2016-001106-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001106-42.